• 1. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 2. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 3. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502

Cholest-5-en-3-ol (3b)-, 9-anthracenecarboxylate (9CI) and Its Significance in Modern Chemical Research

Cholest-5-en-3-ol (3b)-, 9-anthracenecarboxylate (9CI), a complex organic compound with the CAS number 2641-40-9, has garnered significant attention in the field of chemical biology and pharmaceutical research. This heterocyclic derivative combines the structural features of cholestane and anthracene, making it a versatile molecule with potential applications in drug discovery and material science. The unique arrangement of its functional groups allows for diverse chemical modifications, which has spurred extensive investigation into its properties and applications.

The molecular structure of Cholest-5-en-3-ol (3b)-, 9-anthracenecarboxylate (9CI) consists of a steroidal backbone linked to an anthracene moiety. This combination imparts distinct physicochemical properties, including solubility, stability, and reactivity, which are critical factors in its utility as a research tool. The steroid core provides a scaffold that can be modified to enhance binding affinity to biological targets, while the anthracene group offers opportunities for fluorescence-based assays and photochemical studies.

In recent years, the pharmaceutical industry has shown increasing interest in bioconjugates like Cholest-5-en-3-ol (3b)-, 9-anthracenecarboxylate (9CI) due to their potential as probes and intermediates in drug development. Researchers have leveraged its dual functionality to create novel therapeutic agents targeting various diseases. For instance, studies have explored its role in modulating enzyme activity and receptor binding, providing insights into mechanisms underlying conditions such as hyperlipidemia and inflammation.

One of the most compelling aspects of Cholest-5-en-3-ol (3b)-, 9-anthracenecarboxylate (9CI) is its fluorescent properties, which have been exploited in high-throughput screening assays. The anthracene moiety emits light upon excitation, allowing researchers to monitor interactions between the compound and biological molecules with high sensitivity. This capability has been particularly valuable in identifying lead compounds for drug discovery pipelines. Additionally, the steroidal component enhances membrane permeability, making it an attractive candidate for delivering bioactive molecules across biological barriers.

The synthesis of Cholest-5-en-3-ol (3b)-, 9-anthracenecarboxylate (9CI) involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions and stereoselective transformations, have been employed to achieve high yields and purity. These methodologies highlight the compound's significance as a benchmark for synthetic chemists seeking to develop novel molecular architectures.

Recent academic research has begun to explore the potential of Cholest-5-en-3-ol (3b)-, 9-anthracenecarboxylate (9CI) in materials science. Its ability to form stable complexes with metals and other small molecules has led to investigations into its use as a ligand in catalysis. Furthermore, its photophysical properties make it a candidate for developing organic semiconductors and optoelectronic devices. These applications underscore the compound's versatility beyond traditional pharmaceutical contexts.

The toxicological profile of Cholest-5-en-3-ol (3b)-, 9-anthracenecarboxylate (9CI) is another area of active investigation. While preliminary studies suggest low toxicity at moderate concentrations, further research is needed to fully understand its safety profile. This is particularly important given its potential use in clinical settings. Researchers are employing computational modeling and experimental techniques to assess its metabolic stability and potential side effects.

In conclusion, Cholest-5-en-3-ol (3b)-, 9-anthracenecarboxylate (9CI) represents a fascinating example of how structural innovation can yield compounds with broad utility across multiple scientific disciplines. Its unique combination of cholestanic and anthracenic features opens doors for advancements in drug development, materials science, and biochemical research. As synthetic methodologies continue to evolve, it is likely that new applications for this remarkable molecule will emerge.

• 604-32-0(Cholesterol Benzoate)
• 6732-01-0(Cholesterol Hydrogen Phthalate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)